Sinovac Biotech Ltd
SVA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001084201
No open-market purchases or sales by Sinovac Biotech Ltd insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $224.9M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Sinovac Biotech Ltd changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 30 | 8 | −22 |
| Shares | 11.9M | 3.12M | −8.74M (−73.7%) |
| Value | $43.2M | $342.0M | +$298.8M (+691.4%) |
New holders (0)
Institutions that held Sinovac Biotech Ltd at the end of Q4 2023 but not at the end of Q3 2023.
None.
Sold out (22)
Institutions that held Sinovac Biotech Ltd at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Vivo Capital, LLC | 5,900,000 | $38.2M |
| Renaissance Technologies LLC | 2,375,841 | $1.54M |
| State Street Corp | 160,875 | $1.04M |
| Geode Capital Management, LLC | 27,717 | $179.3K |
| Susquehanna International Group, LLP | 16,430 | $106.3K |
| UBS Group AG | 9,095 | $58.8K |
| Morgan Stanley | 6,879 | $44.5K |
| JPMorgan Chase & Co | 3,000 | $19.4K |
| Wells Fargo & Company | 1,661 | $10.7K |
| Yorktown Management & Research Co Inc | 149,786 | $4.49K |
| Group One Trading, L.P. | 412 | $2.67K |
| Northwestern Mutual Wealth Management Co | 102 | $660 |
| US Bancorp | 127 | $0 |
| Bank of America Corp | 426 | $0 |
| Northern Trust Corp | 13,787 | $0 |
| Clearstead Advisors, LLC | 500 | $0 |
| Royal Bank of Canada | 533 | $0 |
| Tower Research Capital LLC (TRC) | 424 | $0 |
| Skandinaviska Enskilda Banken AB (publ) | 40,000 | $0 |
| Spark Investment Management LLC | 29,100 | $0 |
| Advisor Group Holdings, Inc. | 1,362 | $0 |
| EverSource Wealth Advisors, LLC | 4 | $0 |